Early atrophy of pallidum and accumbens nucleus in Huntington’s disease
✍ Scribed by Simon J. A. van den Bogaard; Eve M. Dumas; Tanka P. Acharya; Hans Johnson; Douglas R. Langbehn; Rachael I. Scahill; Sarah J. Tabrizi; Mark A. van Buchem; Jeroen van der Grond; Raymund A. C. Roos; TRACK-HD Investigator Group
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 711 KB
- Volume
- 258
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Huntington's disease (HD) produces progressive and ultimately widespread impairment of brain function. Neostriatal atrophy alone cannot account for whole-brain losses seen postmortem, and the mutant huntingtin protein and its neuropathologic sequelae are evident throughout the brain. Whole-brain atr
## Abstract Therapeutic trials in Huntington's disease (HD) are challenging as clinical progression is slow and variable and reliable biomarkers are lacking. We used magnetic resonance imaging and the brain boundary shift integral to quantify whole‐brain atrophy rates over 1 year in early and prema